Sanofi A/S: Financial statements 2023
CVR: 19064301
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Sanofi A/S (CVR 19064301) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 527,584,000 and a net result of DKK 3,697,000 compared with DKK 15,919,000 the year before. That is a decrease of 0.6% compared with the year before. The profit margin was 0.7%. Equity in the 2023 report amounted to DKK 47,403,000. The solvency ratio was 28.5%. The company had 83 employees in the financial year.
- Revenue
- DKK 527,584,000
- Gross Profit
- DKK 102,537,000
- Profit/Loss
- DKK 3,697,000
- Equity
- DKK 47,403,000
- Total Assets
- DKK 166,242,000
- Employees
- 83
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 527.6 mio. | 102.5 mio. | 3.7 mio. | 47.4 mio. | 83 |
| 2022 | 530.9 mio. | 115 mio. | 15.9 mio. | 43.7 mio. | 85 |
| 2021 | 591.1 mio. | 135.7 mio. | 22 mio. | 69.3 mio. | 86 |
| 2020 | 563.5 mio. | 204.3 mio. | 67.2 mio. | 77.2 mio. | 100 |
| 2019 | 485.7 mio. | 114.9 mio. | 7.2 mio. | 23.3 mio. | 99 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Sanofi A/S has won the tender "Udbud af rammekontrakt vedrørende pertussis vaccine (kighoste) 2024-2028" issued by Statens Serum Institut worth 1 DKK.
Sanofi A/S has published its annual report for 2022. Revenue came to DKK 530,879,000, and the net result was DKK 15,919,000.
About Sanofi A/S
Sanofi A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named SANOFI-AVENTIS DENMARK A/S and AVENTIS PHARMA A/S. The management consists of Odd Arne Gabriel Johannessen. The board consists of Birgitte Fyhn (chair), Hao Zheng and Odd Arne Gabriel Johannessen. The company is owned by Sanofi-Aventis Participations. The company has 87 employees (2026). In 2025, the company reported revenue of DKK 442,343,000 and a net result of DKK 5,043,000 compared with DKK 6,217,000 the year before. Equity in the 2025 report amounted to DKK 58,663,000.